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Summary  The  cycling  (addition  and  removal)  of  O-linked  N-acetylglucosamine  (O-GlcNAc)  on
serine or  threonine  residues  of  nuclear  and  cytoplasmic  proteins  serves  as  a  nutrient  sensor
via the  hexosamine  biosynthetic  pathway’s  production  of  UDP-GlcNAc,  the  donor  for  the  O-
GlcNAc transferase  (OGT).  OGT  is  exquisitely  sensitive  both  in  terms  of  its  catalytic  activity
and by  its  speciﬁcity  to  the  levels  of  this  nucleotide  sugar.  UDP-GlcNAc  is  a  major  node  of
metabolism  whose  levels  are  coupled  to  ﬂux  through  the  major  metabolic  pathways  of  the  cell.
O-GlcNAcylation  has  extensive  crosstalk  with  protein  phosphorylation  to  regulate  signalling
pathways  in  response  to  ﬂux  through  glucose,  amino  acid,  fatty  acid,  energy  and  nucleotide
metabolism.  Not  only  does  O-GlcNAcylation  compete  for  phosphorylation  sites  on  proteins,  but
also over  one-half  of  all  kinases  appear  to  be  O-GlcNAcylated,  and  many  are  regulated  by  O-
GlcNAcylation.  O-GlcNAcylation  is  also  fundamentally  important  to  nutrient  regulation  of  gene
expression.  OGT  is  a  polycomb  gene.  Nearly  all  RNA  polymerase  II  transcription  factors  are  O-
GlcNAcylated,  and  the  sugar  regulates  their  activities  in  many  different  ways,  depending  upon
the transcription  factor  and  even  upon  the  speciﬁc  O-GlcNAc  site  on  the  protein.  O-GlcNAc  is
part of  the  histone  code,  and  the  sugar  affects  the  modiﬁcation  of  histones  by  other  epigenetic
marks. O-GlcNAcylation  regulates  DNA  methylation  by  the  TET  family  of  proteins.  O-GlcNAc
modiﬁcation  of  the  basal  transcription  machinery  is  required  for  assembly  of  the  pre-initiation
complex in  the  transcription  cycle.  Dysregulated  O-GlcNAcylation  is  directly  involved  in  the
aetiology  of  the  major  chronic  diseases  associated  with  ageing.
© 2015  The  Author.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CC  BY
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he  modiﬁcation  of  nuclear  and  cytoplasmic  proteins  by
-linked  N-acetylglucosamine  (O-GlcNAc)  was  discovered
bout  thirty  years  ago  (Torres  and  Hart,  1984;  Holt  and
art,  1986).  Until  then,  it  was  widely  regarded  not  only  in
extbooks,  but  also  by  glycobiology  experts,  that  protein
lycosylation  only  occurred  in  the  lumenal  or  extracellu-
ar  compartments  of  cells.  Early  studies  established  that
-GlcNAcylation  is  particularly  abundant  within  the  nucleus
Holt  and  Hart,  1986;  Holt  et  al.,  1987a;  Park  et  al.,  1987;
elly  and  Hart,  1989),  but  also  occurs  on  many  cytoskele-
al  and  other  cytosolic  proteins  (Holt  et  al.,  1987b;  Hart
t  al.,  1988).  Studies  also  showed  that  O-GlcNAc  cycles
apidly  on  proteins  in  response  to  stimuli,  suggesting  that  it
s  a  regulatory  modiﬁcation  analogous  to  protein  phosphor-
lation  (Kearse  and  Hart,  1991;  Roquemore  et  al.,  1992).
ork  from  several  laboratories  in  the  past  three  decades
ave  shown  that  not  only  is  O-GlcNAc  amongst  the  most
bundant  and  wide-spread  of  post-translational  modiﬁca-
ions,  but  also  that  the  cycling  sugar  serves  as  a  nutrient
ensor  to  regulate  nearly  all  aspects  of  cellular  physiology
for  recent  reviews:  Hart  et  al.,  2011;  Slawson  and  Hart,
011;  Hardiville  and  Hart,  2014)  (Fig.  1).  OGT  is  essen-
ial  in  mammals  and  plants,  even  at  the  single  cell  level
Shaﬁ  et  al.,  2000;  Hartweck  et  al.,  2002;  O’Donnell  et  al.,
004;  Olszewski  et  al.,  2010).  Highlights  of  its  many  func-
ions,  which  depend  upon  protein  and  even  upon  the  sites
n  the  protein  to  which  the  sugar  is  attached,  include:  (1)  It
s  essential  for  both  B-  and  T-lymphocyte  activation  (Golks
t  al.,  2007).  (2)  It  regulates  many  protein—protein  interac-
ions  (Lim  and  Chang,  2009a,b;  Roos  et  al.,  1997;  Hiromura
t  al.,  2003;  Wells  et  al.,  2011).  (3)  Nutrients  regulate  our
ircadian  clocks  via  the  cycling  of  O-GlcNAc  on  transcrip-
ion  factors  (Durgan  et  al.,  2011;  Kim  et  al.,  2012;  Hart,
013;  Kaasik  et  al.,  2013).  (4)  Multiple  subunits  of  the  pro-
easome  are  O-GlcNAcylated  and  the  sugar  regulates  the
ctivity  of  this  degradation  complex  (Zhang  et  al.,  2003;
iu  et  al.,  2004;  Bowe  et  al.,  2006).  (5)  O-GlcNAc  has  a
ynamic  interplay  with  phosphorylation,  ubiquitination  and
ther  key  regulatory  protein  modiﬁcations,  allowing  nutri-
nts  to  regulate  known  signalling  pathways  (Wang  et  al.,
010a;  Zeidan  and  Hart,  2010;  Trinidad  et  al.,  2012;  Ruan
t  al.,  2013).  (6)  O-GlcNAcylation  plays  a  direct  role  in  neu-
onal  functions,  including  learning  and  memory  and  synaptic
esicle  trafﬁcking  (Trinidad  et  al.,  2012;  Cole  and  Hart,
999,  2001;  Lagerlof  and  Hart,  2014;  Vosseller  et  al.,  2006;
rancisco  et  al.,  2009;  Tallent  et  al.,  2009;  Skorobogatko
t  al.,  2014;  Trinidad  et  al.,  2013).  (7)  O-GlcNAc  cycling
egulates  growth  hormone  signalling  in  plants  (Scott  et  al.,
006).  (8)  Increased  O-GlcNAcylation  protects  cells  from
a
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cute  stresses,  such  as  heat,  high  salt,  ultraviolet  light
nd  hypoxia,  among  others  (Zachara  et  al.,  2004;  Slawson
t  al.,  2006;  Cheung  and  Hart,  2008;  Zachara,  2012).  (9)
-GlcNAcylation  also  regulates  translation  and  ribosome
iogenesis  (Ohn  et  al.,  2008;  Zeidan  et  al.,  2010),  but
uch  more  work  in  this  area  is  needed.  (10)  Nutrients  reg-
late  transition  through  the  cell  cycle  by  O-GlcNAcylation
nd  abnormal  increases  in  OGT  lead  to  polyploidy,  a  com-
on  feature  of  cancer  cells  (Wang  et  al.,  2010a,b;  Slawson
t  al.,  2005,  2008).  (11)  O-GlcNAcylation  is  up-regulated  in
ll  cancers  examined  to  date,  and  in  chronic  lymphocytic
eukaemia  the  extent  of  O-GlcNAcylation  of  the  leukocytes
orrelates  with  patient  prognosis  (Slawson  and  Hart,  2011;
hou  and  Hart,  2001;  Caldwell  et  al.,  2010;  Slawson  et  al.,
010;  Yi  et  al.,  2012;  Ma  and  Vosseller,  2013;  Shi  et  al.,  2010;
ynch  et  al.,  2012;  Ma  and  Vosseller,  2014).  (12)  Decreased
-GlcNAcylation,  due  to  reduced  glucose  utilization  in  the
rain,  is  directly  involved  in  the  aetiology  of  Alzheimer’s
isease,  and  inhibitors  of  O-GlcNAcase  show  promise  as  ther-
peutics  (Yuzwa  and  Vocadlo,  2014;  Zhu  et  al.,  2014;  Dias
nd  Hart,  2007;  Arnold  et  al.,  1996).  This  list  represents
nly  a  few  of  the  many  functions  of  this  ubiquitous  pro-
ein  modiﬁcation,  which  thus  far  has  been  reported  on  over
our  thousand  proteins.  However,  the  number  of  nuclear  and
ytoplasmic  proteins  modiﬁed  is  likely  much  larger.  In  this
hort  review,  I  will  focus  on  the  fundamental  importance  of
-GlcNAcylation  in  transcription  and  also  on  its  ubiquitous
mportance  to  nutrient  modulation  of  cellular  signalling.
-GlcNAcylation is fundamentally important to
utrient regulation of transcription
ome  of  the  earliest  work  on  O-GlcNAcylation  showed  that
t  is  highly  enriched  in  chromatin  and  visualization  of  Drop-
ophila  polytene  chromosomes  showed  that  the  sugar  is
ocalized  at  active  sites  of  transcription  (Kelly  and  Hart,
989).  The  IIa  form  of  RNA  polymerase  II,  which  is  the  form
f  the  enzyme  involved  in  initiation  of  transcription,  was
ound  to  be  extensively  O-GlcNAcylated  on  its  C-terminal
CTD)  domain  (Kelly  et  al.,  1993).  O-GlcNAcylation  of  the
TD  is  mutually  exclusive  to  phosphorylation  of  the  CTD,
hich  produces  the  RNA  polymerase  IIo  isoform,  the  form  of
he  enzyme  involved  in  elongation  (Comer  and  Hart,  2000,
001).  Using  more  modern  methods,  like  high-throughput
hIP  analyses  in  both  mammalian  cells  and  Caenorhabdi-
is  elegans, both  cycling  enzymes,  OGT  and  OGA,  as  well
s  O-GlcNAc  itself,  are  found  to  be  highly  localized  at  the
tart  sites  of  thousands  of  genes  (Lewis  and  Hanover,  2014;
anuncolo  et  al.,  2012).  In  a  B  lymphocyte  cell  line,  par-
ial  knock  down  of  OGT  by  shRNA,  strikingly  reduces  the
O-GlcNAcylation  &  cell  physiology  51
Figure  1  O-GlcNAcylation  serves  as  a  nutrient  sensor  to  regulate  many  processes  of  cell  physiology.  UDP-GlcNAc,  the  high-
energy sugar  donor  for  O-GlcNAcylation  is  a  major  node  of  metabolism.  In  fact,  ﬂux  through  glucose-,  amino  acid-,  fatty  acid-
and nucleotide-metabolism  all  directly  affect  the  concentrations  of  UDP-GlcNAc  formed  by  the  hexosamine  biosynthetic  pathway.
In turn,  the  O-GlcNAc  transferase  (OGT)  is  exquisitely  sensitive  the  concentrations  of  UDP-GlcNAc  in  terms  of  its  activity  and  its
speciﬁcity. Removal  of  O-GlcNAc  is  catalyzed  by  the  enzyme  O-GlcNAcase  (OGA).  The  interplay  of  O-GlcNAc  cycling  and  phosphate
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transcription  of  many  genes,  concomitant  with  reduced
binding  of  the  transcription  machinery  to  the  promoters.
In  an  in  vitro  transcription  system  using  the  adenoviral  E3
promoter  and  HeLa  cell  nuclear  extracts,  inhibitors  of  OGT
and  OGA  blocked  transcription,  but  only  if  they  are  added
prior  to  initiation,  but  not  after  elongation  has  begun  (Lewis
and  Hanover,  2014;  Ranuncolo  et  al.,  2012;  Lewis,  2013).
These  data  strongly  suggest  that  O-GlcNAcylation  is  required
for  assembly  of  the  transcription  complex  at  the  promoter,
and  its  removal  is  required  for  elongation  to  take  place,  a
model  proposed  nearly  twenty-years  ago  (Comer  and  Hart,
1999).  The  recent  discovery  that  OGT  is  a  polycomb  gene,
which  regulates  large  sets  of  developmentally  important
genes,  such  as  HOX  genes,  further  supports  the  fundamental
importance  of  O-GlcNAc  cycling  in  transcriptional  regulation
(Myers  et  al.,  2011;  Sinclair  et  al.,  2009;  Gambetta  et  al.,
2009).
Nearly  all  RNA  polymerase  II  transcription  factors  are
extensively  O-GlcNAcylated  (Ozcan  et  al.,  2010).  Among  the
earliest  shown  to  be  O-GlcNAcylated  is  the  transcription
factor,  Sp1,  which  is  not  only  one  of  the  most  extensively
modiﬁed  of  all  O-GlcNAcylated  proteins,  but  also  is  one
of  the  most  important  ‘housekeeping’  transcription  factors
in  cells  (Jackson  and  Tjian,  1988).  O-GlcNAcylation  of  Sp1
may  be  important  to  glucose  toxicity  and  abnormal  gene
t
O
t
e every  aspect  of  cellular  physiology.
xpression  in  certain  tissues  in  diabetes  (Donovan  et  al.,
014;  Majumdar  et  al.,  2004).  The  presence  of  O-GlcNAc
n  transcription  factors  was  often  used  to  purify  them  by
ectin-afﬁnity  chromatography  (Jackson  and  Tjian,  1989).
-GlcNAc  regulates  the  functions  of  transcription  factors  in
lmost  every  conceivable  way,  depending  upon  the  site  and
ranscription  factor,  such  as  by  regulating  nuclear  localiza-
ion,  DNA  binding  (Kang  et  al.,  2013),  turnover  (Kaasik  et  al.,
013;  Ruan  et  al.,  2013),  transactivation  (Ramakrishnan
t  al.,  2013)  and  interactions  with  other  components  of
he  transcription  machinery  (Lim  and  Chang,  2009a,b,c;
iromura  et  al.,  2003).  Host  cell  factor  1  (HCF-1),  which
as  more  than  twelve  O-GlcNAc  sites,  regulates  mitosis,
he  cell  cycle  and  is  key  to  Herpes  viral  infections  (Myers
t  al.,  2013).  Remarkably,  OGT  not  only  extensively  mod-
ﬁes  HCF-1,  but  also  by  using  UDP-GlcNAc  at  is  active  site
s  part  of  the  molecular  mechanism,  it  acts  as  a  pro-
ease  to  cleave  the  protein  into  multiple  fragments,  each
ith  unique  functions  (Lazarus  et  al.,  2013).  It  is  pos-
ible  that  this  unique  proteolysis  mechanism  might  also
ccur  on  other  glycosyltransferases?  Nutrients  help  to  ﬁne
une  our  circadian  clocks  by  using  the  interplay  between
-GlcNAcylation,  phosphorylation  and  ubiquitination  to  con-
rol  the  transcription  cycles  that  comprise  the  clock  (Durgan
t  al.,  2011;  Kim  et  al.,  2012;  Hart,  2013;  Kaasik  et  al.,
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013).  NFB,  the  most  important  transcription  factor  regu-
ating  cells  of  our  immune  system,  is  regulated  via  multiple
echanisms  that  involve  O-GlcNAcylation  of  its  speciﬁc  sub-
nits  (Ramakrishnan  et  al.,  2013;  Allison  et  al.,  2012).
-GlcNAcylation  is  part  of  the  mechanism  that  allows  dif-
erent  receptors  to  share  the  same  signalling  pathway,  but
till  result  in  activation  of  different  genetic  programmes.  For
xample,  in  the  same  cells,  signalling  of  the  T-cell  receptor
TCR)  through  NFB  requires  O-GlcNAcylation  of  the  c-Rel
ubunit,  while  signalling  through  NfkB  by  the  tumour  necro-
is  factor  receptor  (TNFR)  does  not  require  O-GlcNAcylation
f  the  c-Rel  subunit  (Ramakrishnan  et  al.,  2013).  Nearly  all
f  the  components  of  the  basal  transcription  machinery  are
-GlcNAcylated  and  emerging  evidence  suggests  that  cycling
f  the  sugar  on  the  TATA-binding  protein  is  key  to  nutrient
egulation  of  TBP’s  interaction  with  DNA  (Comer  and  Hart,
999).
O-GlcNAc  is  part  of  the  histone  code  with  the  sugar  modi-
cation  localized  in  the  tail  region  of  histones  (Sakabe  et  al.,
010).  However,  some  of  the  O-GlcNAc  sites  on  histones  are
ocated  at  regions  of  the  nucleosome  in  intimate  contact
ith  the  DNA.  O-GlcNAc  cycles  on  histones  with  the  cell
ycle  and  with  altered  gene  expression  due  to  exposure  to
tress  (Sakabe  et  al.,  2010).  Histone  O-GlcNAcylation  also
ppears  to  regulate  other  histone  marks  (Sakabe  and  Hart,
010).  Strikingly,  enzymes  that  methylate  DNA  to  form  5-
ydroxymethylcytosine,  an  important  epigenetic  mark,  not
nly  target  OGT  to  chromatin,  but  also  are  themselves  reg-
lated  by  O-GlcNAcylation  (Chen  et  al.,  2013;  Deplus  et  al.,
013;  Zhang  et  al.,  2014).  It  is  now  clear  that  O-GlcNAc  is
ot  only  a  bona  ﬁde  epigenetic  modiﬁcation  on  its  own,
ut  also  that  modest  increases  in  OGT  by  a  twofold  over-
xpression  in  cells,  dramatically  alters  the  modiﬁcation  of
istones  by  other  well-studied  epigenetic  modiﬁcations  at
ey  sites  on  histones,  including  phosphorylation,  methyla-
ion  and  acetylation  (Sakabe  and  Hart,  2010).  Thus,  while
e  know  very  little  about  the  mechanistic  functions  of  spe-
iﬁc  O-GlcNAcylation  on  proteins  involved  in  transcription,
t  is  now  abundantly  clear  that  research  in  this  area  is  critical
o  nearly  every  aspect  of  our  understanding  of  the  molecular
rocesses  controlling  gene  expression.
utrient regulation of  signalling occurs by
xtensive crosstalk between O-GlcNAcylation
nd phosphorylation
t  present,  thousands  of  O-GlcNAcylation  sites  have  been
apped  on  proteins  (Hart  et  al.,  2007,  2011).  Virtually  all
f  these  sites  are  on  so-called  unstructured  loops  when  the
rystal  structure  is  known.  Since  crystallographers  remove
ll  post-translational  modiﬁcations  when  crystallizing  pro-
eins,  it  seems  likely  that  these  regulatory  loops  do  indeed
ave  speciﬁc  structures  when  they  are  actually  modiﬁed
s  they  are  in  cells.  On  many  proteins,  the  same  hydroxyl
roup  on  the  polypeptide  is  reciprocally  occupied  by  either
 phosphate  or  O-GlcNAc,  depending  upon  the  cellular  status
Wang  et  al.,  2010a;  Zeidan  and  Hart,  2010;  Trinidad  et  al.,
012;  Hart  et  al.,  1996;  Copeland  et  al.,  2008).  For  example,
he  wild-type  c-Myc  oncoprotein,  alternatively  either  has  a
hosphate  or  a  O-GlcNAc  at  Thr58,  which  is  the  site  most
utated  in  human  lymphomas  that  cause  this  transcription
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actor  to  become  an  oncoprotein.  In  non-growing  cells  Thr58
f  c-Myc  is  O-GlcNAcylated,  but  rapidly  becomes  phospho-
ylated  when  cells  are  stimulated  to  divide  (Chou  et  al.,
995a,b;  Kamemura  et  al.,  2002).  There  are  many  proteins
here  the  O-GlcNAc  and  phosphate  are  not  at  the  exact
ame  site,  yet  the  population  of  molecules  that  are  phospho-
ylated  do  not  contain  O-GlcNAc  and  vice  versa  (Chou  et  al.,
992).  There  are  other  proteins,  such  as  insulin  receptor
ubstrates  (IRS),  which  contain  many  sites  of  both  phos-
horylation  and  O-GlcNAcylation  simultaneously  at  different
ites  and  reciprocally  at  shared  sites  (Park  et  al.,  2005;  Ball
t  al.,  2006;  Klein  et  al.,  2009).  Given  the  critical  impor-
ance  of  IRS  proteins  in  insulin  and  growth  factor  signalling,
t  is  not  surprising  that  these  proteins  are  regulated  in  such
 complex  way  both  nutrients  and  energy-dependent  phos-
horylation.  Given  the  abundance  of  both  phosphorylation
nd  O-GlcNAcylation  and  the  fact  that  they  compete  for
he  same  residues  on  proteins,  it  is  not  surprising  that  the
ell  would  use  their  interplay  to  tune  signalling  processes  in
esponse  to  nutrients.
Proteomic  analyses  revealed  how  extensive  this  crosstalk
etween  phosphorylation  and  O-GlcNAcylation  actually  is.
reating  cells  with  an  O-GlcNAcase  inhibitor  elevates  global
-GlcNAcylation  about  threefold.  Quantitative  analysis  of
hosphorylation  occupancy  at  seven  hundred  sites  showed
hat  nearly  every  actively  cycling  site  of  phosphorylation  was
ffected,  either  up  or  down,  by  altering  the  global  O-GlcNAc
evels  (Wang  et  al.,  2008).  Decreased  phosphorylation  when
-GlcNAcylation  was  increased  was  expected  from  the  pre-
umed  reciprocal  relationship  of  the  two  modiﬁcations.  Why
hen  did  phosphate  site  occupancy  at  one  hundred  and
orty-eight  sites  increase  when  global  O-GlcNAcylation  was
ncreased?  Of  course,  we  now  know  that  many,  if  not  most
inases  are  not  only  modiﬁed  by  O-GlcNAcylation,  but  also
everal  studies  have  shown  that  kinases  are  indeed  regu-
ated  by  the  sugar  modiﬁcation.  OGT  associates  with  protein
hosphatases,  indicating  that  the  same  enzyme  complex
ay  remove  the  phosphate  and  attach  the  sugar  without
eleasing  the  polypeptide  (Wells  et  al.,  2004).  Both  OGT
nd  OGA  are  regulated  by  phosphorylation  (Song  et  al.,
008;  Bullen  et  al.,  2014;  Alonso  et  al.,  2014).  Thus,  the
rosstalk  between  phosphorylation  and  O-GlcNAcylation  is
ot  only  due  to  competition  at  the  level  of  site  occupancy
n  polypeptides,  but  also  is  controlled  by  each  modiﬁcation
egulating  the  other’s  cycling  enzymes.
Many  kinases  are  dynamically  O-GlcNAcylated,  and
ecent  analyses  using  protein  arrays  suggest  that  over  one-
alf  of  all  kinases  are  modiﬁed  by  the  sugar  (Dias  et  al.,
012).  O-GlcNAcylation  occurs  on  all  families  of  kinases
hether  they  are  classiﬁed  in  terms  of  evolutionary  rela-
ionship  or  functional  types.  Thus  far,  every  O-GlcNAcylated
inase  studied  is  regulated  by  the  sugar  in  some  fashion.
or  example,  calcium  calmodulin  kinase  IV  (CAMKIV),  which
ery  important  in  regulation  if  neuronal  functions  and  in
ancreatic  beta  cell  functions,  is  activated  by  calmodulin
nd  phosphorylation  at  Thr200.  Upon  nerve  cell  depolarisa-
ion,  phosphorylation  of  Thr200  on  CAMKII  increases,  while
-GlcNAcylation  at  several  sites,  but  most  importantly  at
er189  decreases  (Dias  et  al.,  2009).  Ser189  is  located  in
he  ATP-binding  pocket  of  CAMKIV  and  occupancy  by  O-
lcNAc  blocks  binding  of  ATP  to  the  kinase.  O-GlcNAcase
ust  remove  the  sugar  before  CAMKIV  can  be  activated.  In
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turn,  activated  CAMKIV  modiﬁes  OGT  and  activates  it  (Song
et  al.,  2008),  creating  a  cycle  that  regulates  the  activation  of
this  important  kinase.  In  contrast,  CAMKII,  which  is  a  critical
regulator  of  our  cardiac  contractility  and  is  also  important
in  nerve  cells,  is  normally  activated  by  phosphorylation  of
Thr286,  which  opens  up  the  protein  (Erickson  et  al.,  2013).
However,  in  diabetic  hearts  Ser279  becomes  abnormally
O-GlcNAcylated  causing  the  enzyme  to  become  constitu-
tively  active.  This  abnormal  activation  contributes  directly
to  the  arrhythmias  associated  with  diabetic  cardiomyopa-
thy.  In  dividing  and  growing  cells,  OGT  is  mostly  within  the
nucleus.  However,  in  non-dividing  differentiated  cells,  such
as  skeletal  muscle  and  neurons,  it  is  mostly  cytoplasmic
and  its  nuclear  localization  is  regulated.  The  major  energy
sensing  kinase  of  cells,  adenosine  monophosphate  activated
kinase  (AMPK),  phosphorylates  OGT  at  Thr444  inducing  its
nuclear  localization  in  skeletal  muscle  cells  (Bullen  et  al.,
2014).  AMPK  itself  is  O-GlcNAcylated  on  its  alpha  1  and  2  and
gamma  regulatory  subunits  and  global  inhibition  of  O-GlcNAc
cycling  blunts  the  overall  activation  of  AMPK.  The  casein
kinase  II  (CKII)  alpha  subunit  is  O-GlcNAcylated  at  Ser347
proximal  to  its  phosphorylation  at  Thr344  (Tarrant  et  al.,
2012).  Remarkably,  using  protein  arrays  to  assay  substrate
speciﬁcity,  the  phosphorylated  and  O-GlcNAcylated  isoforms
were  shown  to  have  different  substrate  selectivity.  This  ﬁnd-
ing  could  have  profound  implications  with  respect  to  how
individual  modiﬁcations  regulate  signalling.  Protein  kinase  C
isoforms  are  regulated  by  O-GlcNAcylation  (Matthews  et  al.,
2005;  Robles-Flores  et  al.,  2008).  Activation  of  AKT  (protein
kinase  B)  is  also  regulated  by  O-GlcNAcylation  in  certain  cell
types  (Park  et  al.,  2005;  Gandy  et  al.,  2006;  Kang  et  al.,
2008).  O-GlcNAcylation  of  phosphofructokinase  1  (PFK-1),
which  is  the  key  enzyme  regulating  glycolysis,  regulates
growth  and  metabolism,  particularly  of  cancer  cells,  by
diverting  ﬂux  of  glucose  into  the  pentose  phosphate  pathway
(Yi  et  al.,  2012).
Conclusions and future directions
In  the  past  three  decades  of  research  on  O-GlcNAcylation,
it  has  become  clear  that  this  ubiquitous  sugar  modiﬁcation
of  proteins  serves  as  a  major  nutrient  sensor  to  regulate
many  aspects  of  cellular  physiology  (Fig.  1).  The  devel-
opment  of  advanced  enrichment  and  mass  spectrometric
methods  to  detect  and  quantify  O-GlcNAc  has  played  a
major  role  in  moving  this  ﬁeld  forward  (Myers  et  al.,  2013;
Wang  et  al.,  2010b;  Alfaro  et  al.,  2012).  While  methods
and  tools  have  improved  (Zachara  et  al.,  2011),  there  still
is  an  acute  need  to  develop  better  approaches  to  eluci-
date  O-GlcNAc’s  functions.  The  availability  of  site-speciﬁc
antibodies,  like  those  available  for  phosphorylation,  would
greatly  advance  the  ﬁeld.  Currently,  the  only  methods  to
alter  the  levels  of  O-GlcNAc,  either  up  or  down,  cause  global
changes.  There  is  an  acute  need  to  be  able  to  increase
or  decrease  the  modiﬁcation  of  proteins  by  O-GlcNAc  on
individual  proteins  or  even  at  individual  sites  to  elucidate
functions.  As  it  is  now  clear  that  O-GlcNAcylation  is  impor-
tant  to  the  aetiology  of  cardiovascular  functions  and  disease
(Zachara,  2012;  Marsh  and  Chatham,  2014;  Karunakaran
and  Jeoung,  2010;  Chatham  and  Marchase,  2010),  cancer
(Slawson  and  Hart,  2011;  Caldwell  et  al.,  2010;  Slawson53
t  al.,  2010;  Ma  and  Vosseller,  2013,  2014),  diabetes  (Hart
t  al.,  2011;  Vaidyanathan  and  Wells,  2014;  Semba  et  al.,
014;  Ma  and  Hart,  2013;  Teo  et  al.,  2010;  Issad  et  al.,
010),  and  Alzheimer’s  disease  (Yuzwa  and  Vocadlo,  2014;
hu  et  al.,  2014;  Dias  and  Hart,  2007;  Alfaro  et  al.,  2012),
hus,  the  need  to  have  more  researchers  in  this  area  are
learly  justiﬁed.  We  will  never  understand  the  molecular
echanisms  controlling  signalling  and  transcription  until  the
esearch  community  focuses  much  more  of  its  efforts  on
-GlcNAcylation,  which  in  the  past  thirty  years  has  largely
een  ignored  by  the  mainstream,  perhaps  mostly  due  to  the
ifﬁculties  in  detecting  it  and  the  lack  of  tools.
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